McKesson Ventures has returned to back a $40m round for Lightship, having co-led a $20m series B last year.

US-based clinical trial services provider Lightship obtained $40m in a funding round on Wednesday that included McKesson Ventures, the corporate venture capital unit of pharmaceuticals distributor McKesson. Define Ventures and private investor Brook Byers co-led the round, while Khosla Ventures and Time Ventures also took part. Founded in 2018, Lightship operates an end-to-end service to…

The rest of this content is only accessible to Corporate Venturing: News, Data, and Events - Global Corporate Venturing Subscribers.

This content is only accessible to subscribers. If you are a subscriber, please sign in. Otherwise, if you would like to try before you buy and haven't previously taken out a free trial, you can do so below. You can also see details on subscriptions by clicking the Subscription Options button.